𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation

✍ Scribed by Mirelman, Anat; Heman, Talia; Yasinovsky, Kira; Thaler, Avner; Gurevich, Tanya; Marder, Karen; Bressman, Susan; Bar-Shira, Anat; Orr-Urtreger, Avi; Giladi, Nir; Hausdorff, Jeffrey M.

Book ID
121397500
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
932 KB
Volume
28
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

G2019S LRRK2 mutation in familial and sp
G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia
✍ Sofya N. Pchelina; Andrei F. Yakimovskii; Olga N. Ivanova; Anton K. Emelianov; A πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract Among mutations associated with autosomal dominant and sporadic Parkinson's disease (PD) the G2019S substitution in the leucine‐rich repeat kinase 2 (LRRK2) gene is the most frequently identified. To estimate its frequency in Russia, we analyzed 208 patients with PD from the Northwester

LRRK2 G2019S mutations are associated wi
LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease
✍ Rachel Saunders-Pullman; Matthew J. Barrett; Kaili M. Stanley; Marta San Luciano πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 70 KB

## Abstract Leucine rich repeat kinase (__LRRK2__) G2019S mutations are presumed to cause PD through a toxic gain of function of the protein kinase. Small molecule kinase inhibitors have been developed for the treatment of certain cancers, and some antioncogenic agents such as sunitinib, may nonspe